Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of CAD 228.60 billion. The enterprise value is 315.62 billion.

Market Cap	228.60B
Enterprise Value	315.62B

Important Dates

The next estimated earnings date is Tuesday, October 29, 2024.

Earnings Date	Oct 29, 2024
Ex-Dividend Date	n/a

Share Statistics

Shares Outstanding	n/a
Shares Change (YoY)	-1.25%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.66B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.92, with an EV/FCF ratio of 47.94.

EV / Earnings	-88.87
EV / Sales	4.14
EV / EBITDA	19.92
EV / EBIT	65.02
EV / FCF	47.94

Financial Position

The company has a current ratio of 0.86, with a Debt / Equity ratio of 0.79.

Current Ratio	0.86
Quick Ratio	0.51
Debt / Equity	0.79
Debt / EBITDA	6.21
Debt / FCF	14.52
Interest Coverage	1.11

Financial Efficiency

Return on equity (ROE) is -2.74% and return on invested capital (ROIC) is 1.27%.

Return on Equity (ROE)	-2.74%
Return on Assets (ROA)	0.94%
Return on Capital (ROIC)	1.27%
Revenue Per Employee	857,988
Profits Per Employee	-40,360
Employee Count	88,000
Asset Turnover	0.25
Inventory Turnover	2.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.90% in the last 52 weeks. The beta is 0.62, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-11.90%
50-Day Moving Average	13.55
200-Day Moving Average	13.21
Relative Strength Index (RSI)	50.07
Average Volume (20 Days)	43,247

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.17

Income Statement

In the last 12 months, Pfizer had revenue of CAD 75.50 billion and -3.55 billion in losses. Loss per share was -0.64.

Revenue	75.50B
Gross Profit	45.43B
Operating Income	4.49B
Pretax Income	-5.70B
Net Income	-3.55B
EBITDA	13.64B
EBIT	4.49B
Loss Per Share	-0.64

Full Income Statement

Balance Sheet

The company has 9.72 billion in cash and 95.61 billion in debt, giving a net cash position of -85.89 billion.

Cash & Cash Equivalents	9.72B
Total Debt	95.61B
Net Cash	-85.89B
Net Cash Per Share	n/a
Equity (Book Value)	120.41B
Book Value Per Share	21.18
Working Capital	-8.20B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.96 billion and capital expenditures -4.37 billion, giving a free cash flow of 6.58 billion.

Operating Cash Flow	10.96B
Capital Expenditures	-4.37B
Free Cash Flow	6.58B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 60.16%, with operating and profit margins of 5.95% and -4.70%.

Gross Margin	60.16%
Operating Margin	5.95%
Pretax Margin	-7.55%
Profit Margin	-4.70%
EBITDA Margin	18.06%
EBIT Margin	5.95%
FCF Margin	8.72%

Dividends & Yields

Pfizer does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.25%
Shareholder Yield	1.25%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 1.83. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.83
Piotroski F-Score	n/a